Varian Medical Systems organises Oncology Summit

Renowned national and international cancer experts from seven countries are meeting to share best practices and exchange knowledge on modern technologies making treatment for cancer patients more precise, accurate and efficient.

 

The Summit is addressing a wide spectrum of topics in the sphere of radiotherapy treatment. 

 

These include major advances in radiation oncology technology, emerging technologies to treat different types of cancer, expanding cancer care access in India and other countries, regulatory issues in radiotherapy practice and new medical options for cancer patients.

 

The Summit has been organized by Varian Medical Systems, the manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery and brachytherapy.

 

The sessions will also cover clinical practise and new clinical trends, developments in radiation oncology treatments involving Varian’s Edge radiosurgery suite, stereotactic ablative body radiotherapy (SABR), RapidArc volumetric treatments, motion management techniques, brachytherapy, imaging, treatment planning software, and knowledge-based solutions designed to help clinicians implement quality clinical practices.

 

The panel discussion during the inaugural session focused on improving access to cancer care in the South Asia region. The panellists emphasized on the importance of quality control in radiotherapy to improve health outcomes and minimise adverse events.

 

John R Adler, MD, Professor of Neurosurgery at Stanford University and Vice President and Chief of New Clinical Applications, Varian Medical Systems said “Advances in radiation oncology are changing the way cancer is treated around the world. Modern medical devices have ushered in a period of personalized medicine, enabling doctors to target tumors non-invasively, with high precision. For instance, SABR (stereotactic ablative body radiotherapy) is a form of therapy which differs from traditional radiotherapy where higher doses are given over a shorter number of treatments. It is an emerging treatment for prostate cancer and a viable alternative, in some cases, to more invasive surgical procedures.”

 

“New techniques are offering patients efficient, minimally invasive alternatives to invasive surgical approaches which entail anaesthesia and long recovery periods in hospitals. Innovative radiotherapy and radiosurgery technologies offer image-guided patient positioning, motion-management, and real-time tumor tracking that have made the approach to fighting cancer more powerful than ever before.” added SK Shrivastava, Professor and Head of the Department of Radiation Oncology, Tata Memorial Hospital.